thisdrug what a medicine's name tells you

WHO naming stem · suffix · 20 listed names

-setron

serotonin receptor antagonists (5-HT3) not fitting into other established groups of serotonin receptor antagonists

WHO's definition, quoted as written in the 2024 stem book
Names only. This page is about -setron as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -setron. So the letters setron sit at the end of the name (…setron).

All 20 names WHO lists under -setron

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

  1. alosetron
  2. arazasetron
  3. azasetron
  4. bemesetron
  5. cilansetron
  6. dolasetron
  7. fabesetron
  8. galdansetron
  9. granisetron
  10. indisetron
  11. itasetron
  12. lerisetron
  13. lurosetron
  14. mirisetron
  15. ondansetron
  16. palonosetron
  17. ramosetron
  18. ricasetron
  19. tropisetron
  20. zatosetron

Decode another name

Decoded

alosetron

Listed INNCarries the WHO stem -setron

  • -setronend of the nameWHO lists it hereWHO definition: serotonin receptor antagonists (5-HT3) not fitting into other established groups of serotonin receptor antagonists

“alosetron” is an INN that WHO lists under -setron in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -setron (Part II B) and the 20 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.